HDAC-IN-54
HDAC-IN-54 is a HDAC inhibitor with an IC50 of 25 nM against human HDAC1, 66 nM against HDAC2, 6.5 nM against HDAC3, and 281 nM against HDAC6. HDAC-IN-54 induces acetylation of α-tubulin and histone H3. HDAC-IN-54 acts synergistically with cisplatin to induce cancer cell apoptosis. HDAC-IN-54 can be used in research related to head and neck cancer, ovarian cancer, and tongue squamous cell carcinoma.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 2098896-13-8
- Formule: C24H32N4O4
- Masse moléculaire:440.54
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
Description
IC50 & Target
|
hHDAC1 25 nM (IC50) |
HDAC2 66 nM (IC50) |
HDAC3 6.5 nM (IC50) |
HDAC6 281 nM (IC50) |
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| A2780 | IC50 |
0.47 μM
Compound: 4j
|
Cytotoxicity against human A2780 cells assessed as cell survival after 72 hrs by MTT assay
Cytotoxicity against human A2780 cells assessed as cell survival after 72 hrs by MTT assay
|
[PMID: 28574690] |
| A2780cisR | IC50 |
1.62 μM
Compound: 4j
|
Cytotoxicity against human A2780cisR cells assessed as cell survival after 72 hrs by MTT assay
Cytotoxicity against human A2780cisR cells assessed as cell survival after 72 hrs by MTT assay
|
[PMID: 28574690] |
| CAL-27 | IC50 |
0.44 μM
Compound: 4j
|
Cytotoxicity against human CAL27 cells assessed as cell survival after 72 hrs by MTT assay
Cytotoxicity against human CAL27 cells assessed as cell survival after 72 hrs by MTT assay
|
[PMID: 28574690] |
In Vitro
HDAC-IN-54 (Compound 4j) (18 h) inhibits cellular HDAC activity in A2780, A2780CisR, Cal27 and Cal27CisR cells, with IC50 values of 0.48, 0.32, 0.27 and 0.35 μM, respectively[1].
HDAC-IN-54 (72 h) reduces the viability of A2780, A2780CisR, Cal27 and Cal27CisR cells, with IC50 values of 0.47, 1.62, 0.44 and 1.13 μM, respectively[1].
HDAC-IN-54 (90 min) potently inhibits recombinant human HDAC1-3 and HDAC6 enzymes, with the strongest inhibitory activity against HDAC3 (IC50 = 6.5 nM), followed by HDAC1 (25.0 nM), HDAC2 (66 nM), HDAC6 (281 nM), and only weak activity against HDAC8 (2750 nM)[1].
HDAC-IN-54 (10 μM; 24 h) induces acetylation of α-tubulin and histone H3 in Cal27 and Cal27CisR cells, confirming that it inhibits both class I HDAC and HDAC6[1].
HDAC-IN-54 (250-500 nM; 48 h preincubation) enhances the sensitivity of Cal27 and Cal27CisR cells to Cisplatin (HY-17394) in a concentration-dependent manner[1].
HDAC-IN-54 (250-500 nM; 48 h preincubation) synergistically enhances Cisplatin-induced apoptosis in Cal27 and Cal27CisR cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:Cal27, Cal27CisR
-
Concentration:10 μM
-
Incubation Time:24 h
-
Result:Induced an increase in acetylation of α-tubulin and histone H3 in both cell lines, with effects more pronounced in Cal27 than in Cal27CisR.
-
Cell Line:Cal27, Cal27CisR
-
Concentration:250 nM, 500 nM
-
Incubation Time:48 h (preincubation); 72 h (total incubation)
-
Result:Reduced the IC50 of Cisplatin from 3.01 μM to 1.95 μM (shift factor = 1.5) in Cal27, and from 50.4 μM to 16.1 μM (shift factor = 3.1) in Cal27CisR at 250 nM.
Reduced the IC50 of Cisplatin from 3.01 μM to 0.78 μM (shift factor = 3.9) in Cal27, and from 50.4 μM to 7.37 μM (shift factor = 6.8) in Cal27CisR at 500 nM.
-
Cell Line:Cal27, Cal27CisR
-
Concentration:250 nM, 500 nM
-
Incubation Time:48 h (preincubation)
-
Result:Induced a significant increase in apoptotic nuclei in Cal27 when combined with Cisplatin at 250 nM and 500 nM.
Induced a significant increase in apoptotic nuclei in Cal27CisR when combined with Cisplatin at 500 nM.
Chemical Information
-
CAS No. 2098896-13-8
-
Masse moléculaire 440.54
-
Formule C24H32N4O4
-
SMILES
O=C(NO)CCCCCN(C(=O)C1=CC=C(C=C1)N(C)C)CC(=O)NCC=2C=CC=CC2
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)